PMVP Q3 2024 Earnings — PMV Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

PMVPPMV Pharmaceuticals, Inc.

$88M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$22M

Net Income

-$19M

EPS (Diluted)

$-0.37

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$17M

Free Cash Flow

-$17M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$223M

Total Liabilities

$26M

Stockholders' Equity

$198M

Cash & Equivalents

$49M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$22M	-$20M	-11.5%
Net Income	-$19M	-$17M	-15.5%